FDA grants breakthrough designation for TLX250-CDx product
Filed with ASX · · 1 page · English
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings CallTelix Pharmaceuticals Limited on 6ix
Story so far
Earlier from Telix Pharmaceuticals
- S&P DJI Announces June 2020 Quarterly Rebalance
- Appendix 4C and Activity Report March 2020 quarter
- Commercial Distribution Agmt for Prostate Cancer Diagnostic
- Telix completes acquisition of licensed production facility
- Telix and partners receive 500k CRC research grant
Later from Telix Pharmaceuticals
- Receipt of $11.4M R&D tax rebate
- Appendix 4C and Activities Report - June 2020 quarter
- Report for half-year to 30 June 2020
- FDA grants orphan drug designation for TLX102
- IRE Distribution Partnership for Prostate Cancer Imaging
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals